AnaptysBio Inc
NASDAQ:ANAB

Watchlist Manager
AnaptysBio Inc Logo
AnaptysBio Inc
NASDAQ:ANAB
Watchlist
Price: 43.8 USD -1.6% Market Closed
Market Cap: 1.2B USD

Wall Street
Price Targets

ANAB Price Targets Summary
AnaptysBio Inc

Wall Street analysts forecast ANAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ANAB is 61.46 USD with a low forecast of 20.2 USD and a high forecast of 105 USD.

Lowest
Price Target
20.2 USD
54% Downside
Average
Price Target
61.46 USD
40% Upside
Highest
Price Target
105 USD
140% Upside
AnaptysBio Inc Competitors:
Price Targets
ORY
Oryzon Genomics SA
128% Upside
002007
Hualan Biological Engineering Inc
26% Upside
BMRN
Biomarin Pharmaceutical Inc
73% Upside
RYTM
Rhythm Pharmaceuticals Inc
27% Upside
2616
CStone Pharmaceuticals
149% Upside
EQ
Equillium Inc
183% Upside
ZYME
Zymeworks Inc
36% Upside
LENZ
Graphite Bio Inc
103% Upside

Revenue
Forecast

Revenue Estimate
AnaptysBio Inc

For the last 10 years the compound annual growth rate for AnaptysBio Inc's revenue is 19%. The projected CAGR for the next 3 years is 28%.

19%
Past Growth
28%
Estimated Growth
Estimates Accuracy
12%
Average Beat

Operating Income
Forecast

Operating Income Estimate
AnaptysBio Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

Net Income Estimate
AnaptysBio Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ANAB's stock price target?
Price Target
61.46 USD

According to Wall Street analysts, the average 1-year price target for ANAB is 61.46 USD with a low forecast of 20.2 USD and a high forecast of 105 USD.

What is AnaptysBio Inc's Revenue forecast?
Projected CAGR
28%

For the last 10 years the compound annual growth rate for AnaptysBio Inc's revenue is 19%. The projected CAGR for the next 3 years is 28%.

Back to Top